ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 131257 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 131257; 2) Community: the network communities that were significantly associated with the response to NSC 131257; 3) Molecule: the relationships between components within communities and NSC 131257; 4) MDR: the compounds that were significantly associated with the NSC 131257.

NSC Compound Enrichment Correlation
NSC 127328 Guanidine, 1-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-3-[4-[[2-(diisopropylamino)ethyl]amino]-6-methyl-2-pyrimidinyl]- 0.0385203205529759 -0.010653288
NSC 102067 6H-Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- 0.0392716453377535 0.23375723
NSC 106246 Null 0.0392716453377535 0.34325987
NSC 113452 Null 0.0392716453377535 0.20634434
NSC 187546 Ethanimidamide, 2-chloro-N-(tricyclo[3.3.1.1(3,7)]dec-1-ylmethyl)-, monohydrochloride 0.0392716453377535 0.3501513
NSC 2039 Bioquin 0.0392716453377535 0.18339599
NSC 266046 Oxaliplatin 0.0392716453377535 0.35502506
NSC 329277 Null 0.0392716453377535 0.42363217
NSC 329515 Kijanimicin sodium salt 0.0392716453377535 0.2755846
NSC 43101 Null 0.0392716453377535 -0.01559022
Total:68  Current:56    [First] [Prev] [Next] [Last]